Prognostic implications of residual disease (RD) tumor-infiltrating lymphocytes (TIL) in triple negative breast cancer (TNBC) after neo-adjuvant chemotherapy (NAC).

被引：0
|
作者：
Luen, Stephen James
Salgado, Roberto
Dieci, Maria Vittoria
Vingiani, Andrea
Curigliano, Giuseppe
Hubbard, Rebekah
Altamirano, Carlos Castaneda
Sanchez, Joselyn
D'Alfonso, Timothy
Cheng, Esther
Garcia, Miluska Castillo
Adams, Sylvia
Ahmed, Fahad
Rimm, David L.
Demaria, Sandra
Symmans, William Fraser
Michiels, Stefan
Loi, Sherene
机构：
[1] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[2] Inst Jules Bordet, Brussels, Belgium
[3] Univ Padua, Padua, Italy
[4] Ist Oncol Veneto IRCCS, Padua, Italy
[5] Ist Eur Oncol, Milan, Italy
[6] Univ Milan, Ist Eur Oncol, Milan, Italy
[7] Univ Texas MD Anderson Canc Ctr, Div Pathol, Houston, TX 77030 USA
[8] Inst Nacl Enfermedades Neoplas, Lima, Peru
[9] Cornell Univ, New York, NY 10021 USA
[10] NYU, Sch Med, Perlmutter Canc Ctr, New York, NY USA
[11] Yale Univ, New Haven, CT USA
[12] Yale Sch Med, New Haven, CT USA
[13] Weill Cornell Med Coll, Dept Radiat Oncol, New York, NY USA
[14] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[15] Inst Gustave Roussy, Villejuif, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.571
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
571
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Differential expressions of immune check point receptors on tumor infiltrating lymphocytes after neo-adjuvant chemotherapy (NAC) in patients with locally advanced breast cancer (LABC)
    Abbasov, Ayxan
    Cetin, Esin
    Cabioglu, Neslihan
    Mollavelioglu, Baran
    Onder, Semen
    Emiroglu, Selman
    Tukenmez, Mustafa
    Muslumanoglu, Mahmut
    Igci, Abdullah
    Deniz, Gunnur
    Ozmen, Vahit
    CANCER RESEARCH, 2020, 80 (16)
  • [32] Evaluation of tumor-infiltrating lymphocytes (TIL) and tumor cell apoptosis as predictive markers for response to neoadjuvant chemotherapy in triple-negative breast cancer
    Ono, M.
    Tsuda, H.
    Shimizu, C.
    Yamamoto, S.
    Shibata, T.
    Kouno, T.
    Tamura, K.
    Ando, M.
    Katsumata, N.
    KInoshita, T.
    Fujiwara, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [33] Prognostic value of transcriptomic analysis in residual post neo-adjuvant triple negative breast cancer tumors
    Aguilar-Mahecha, Adriana
    Majedi, Yasamin
    Elebute, Oluwadara
    Lafleur, Josiane
    Papadakis, Andreas
    Lan, Cathy
    Pelmus, Manuela
    Rashid, Touhidur
    Jenna, Sarah
    Basik, Mark
    CANCER RESEARCH, 2022, 82 (12)
  • [34] Prognostic value of tumor-infiltrating lymphocyte subtypes in residual tumors of patients with triple-negative breast cancer after neoadjuvant chemotherapy
    Bai Yu-Ge
    Gao Guo-Xuan
    Zhang Hong
    Zhang Shuang
    Liu Yin-Hua
    Duan Xue-Ning
    Xu Ling
    中华医学杂志英文版, 2020, 133 (05) : 552 - 560
  • [35] Prognostic value of tumor-infiltrating lymphocyte subtypes in residual tumors of patients with triple-negative breast cancer after neoadjuvant chemotherapy
    Bai, Yu-Ge
    Gao, Guo-Xuan
    Zhang, Hong
    Zhang, Shuang
    Liu, Yin-Hua
    Duan, Xue-Ning
    Xu, Ling
    CHINESE MEDICAL JOURNAL, 2020, 133 (05) : 552 - 560
  • [36] Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer
    Makiko Ono
    Hitoshi Tsuda
    Chikako Shimizu
    Sohei Yamamoto
    Tatsuhiro Shibata
    Harukaze Yamamoto
    Taizo Hirata
    Kan Yonemori
    Masashi Ando
    Kenji Tamura
    Noriyuki Katsumata
    Takayuki Kinoshita
    Yuichi Takiguchi
    Hideki Tanzawa
    Yasuhiro Fujiwara
    Breast Cancer Research and Treatment, 2012, 132 : 793 - 805
  • [37] Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer
    Ono, Makiko
    Tsuda, Hitoshi
    Shimizu, Chikako
    Yamamoto, Sohei
    Shibata, Tatsuhiro
    Yamamoto, Harukaze
    Hirata, Taizo
    Yonemori, Kan
    Ando, Masashi
    Tamura, Kenji
    Katsumata, Noriyuki
    Kinoshita, Takayuki
    Takiguchi, Yuichi
    Tanzawa, Hideki
    Fujiwara, Yasuhiro
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 132 (03) : 793 - 805
  • [38] Prognostic impact of tumor infiltrating lymphocytes (TIL's) and stromal-infiltrating lymphocytes (SIL's) in triple negative breast cancer
    Sherwell-Cabello, S.
    Maffuz-Aziz, A.
    Bautista-Pina, V.
    Labastida-Almendaro, S.
    Camacho-Ramirez, D. A.
    Rios-Luna, N. P.
    Rodriguez-Cuevas, S.
    CANCER RESEARCH, 2016, 76
  • [39] Practical consensus recommendations for neo-adjuvant chemotherapy in triple negative breast cancer
    Bhattacharyya, G. S.
    Walia, M.
    Nandi, M.
    Murli, A.
    Salim, S.
    Rajpurohit, S.
    Shinde, S.
    Aggarwal, S.
    Parikh, P. M.
    SOUTH ASIAN JOURNAL OF CANCER, 2018, 7 (02) : 156 - 158
  • [40] Dissecting the role of tumor-infiltrating lymphocytes (TIL) in patients with high-risk soft-tissue sarcoma (STS) receiving neo-adjuvant chemotherapy (NAC) with regional hyperthermia (RHT)
    Issels, R.
    Bueclein, V.
    Kampmann, E.
    Knoesel, T.
    Noessner, E.
    Subklewe, M.
    Lindner, L.
    ANNALS OF ONCOLOGY, 2016, 27
12345